Generics - Markets & Marketing

Filter

Current filters:

Markets & Marketing

Popular Filters

1 to 25 of 321 results

Daiichi Sankyo launches new generic drugs

Daiichi Sankyo launches new generic drugs

15-12-2014

Japanese pharma major Daiichi Sankyo says its generics subsidiary, Daiichi Sankyo Espha, has launched…

Antibiotics and Infectious diseasesBlopressCardio-vascularCravitDaiichi SankyoElplatGenericsJapanMarkets & MarketingOncology

Teva, Actavis and Mylan launch generic Celebrex capsules in USA

Teva, Actavis and Mylan launch generic Celebrex capsules in USA

10-12-2014

Israel-based generics giant Teva Pharmaceutical Industries said today that it has launched the first…

ActavisAnti-Arthritics/RheumaticsCelebrexGenericsMarkets & MarketingMylanPfizerTeva Pharmaceutcal IndustriesUSA

Europe’s research and generic/biosimilar industries join forces against counterfeiting

Europe’s research and generic/biosimilar industries join forces against counterfeiting

09-12-2014

Trade groups the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the European…

ESMEuropeGenericsMarkets & MarketingPharmaceutical

Nippon Kayaku launches biosimilar Remicade in Japan

Nippon Kayaku launches biosimilar Remicade in Japan

01-12-2014

Japanese drugmaker Nippon Kayaku has launched the sale of Infliximab BS for IV Infusion 100mg, a biosimilar…

Anti-Arthritics/RheumaticsBiosimilarsGenericsinfliximabJapanJohnson & JohnsonMarkets & MarketingNippon KayakuRemicade

Global oncology biosimilars market 2014-2018

28-11-2014

The global oncology biosimilars market is expected to expand at a compound annual growth rate (CAGR)…

BioconBiosimilarsCellTrionDr Reddy's LaboratoriesGenericsGlobalHospiraMarkets & MarketingMylanSandoz

China pharma excipients market to reach $8.9 billion in 2017

China pharma excipients market to reach $8.9 billion in 2017

24-11-2014

Currently, pharmaceutical excipients account for about 2%-3% of China's total output value of pharmaceutical…

ChinaGenericsMarkets & MarketingProduction

Generic versions of Valcyte and Activella hit the US market

20-11-2014

Ireland-domiciled pain drugmaker Endo International says that its Qualitest subsidiary has launched a…

ActivellaAmneal PharmaceuticalsEndo InternationalGenericsLopreezaMarkets & MarketingNovo NordiskOphthalmicsRocheUSAValcyteWomen's Health

Cipla links with SII for affordable pediatric vaccines in Europe

20-11-2014

The European subsidiary of Indian drugmaker Cipla has entered a distribution agreement with Serum Institute…

CiplaEuropeGenericsMarkets & MarketingSerum Institute of IndiaVaccines

Opportunity to promote good antibiotics prescription practices, says EGA

19-11-2014

The European Generic medicines Association (EGA) used the platform of European Antibiotic Awareness Day…

Antibiotics and Infectious diseasesEuropeGenericsMarkets & MarketingPricing

India takes action on spurious and sub-standard drugs

India takes action on spurious and sub-standard drugs

10-11-2014

An American pharmacist and an Indian pharmacologist charged with smuggling four million fake pharmaceuticals…

GenericsIndiaMarkets & MarketingPharmaceuticalPoliticsRegulation

Mylan debuts generic Viramune XR in USA

Mylan debuts generic Viramune XR in USA

31-10-2014

US generic drugmaker Mylan said yesterday that it has launched its nevirapine extended-release tablets,…

Anti-viralsBoehringer IngelheimGenericsMarkets & MarketingMylanUSAViramune

Polish and European generics groups view opportunities for biosimilars

29-10-2014

The European Biosimilars Group – a sector group of the European Generic medicines Association, together…

BiosimilarsEastern EuropeGenericsMarkets & MarketingPolandPricingRegulation

Chinese heparin API market to account for about 80% of global demand; report

Chinese heparin API market to account for about 80% of global demand; report

21-10-2014

It is projected that the heparin active pharmaceutical ingredient (API) in China will achieve an additional…

Cardio-vascularChinaGenericsMarkets & Marketing

Netherlands Pharma market growth held back by govt generics policy

14-10-2014

The Netherlands’ pharmaceutical market value will rise slowly from around $6.7 billion in 2014 to $7.2…

FinancialGenericsHealthcareMarkets & MarketingNetherlands

Growth set to return to CIS by 2015 with Kazakhstan in the lead

Growth set to return to CIS by 2015 with Kazakhstan in the lead

13-10-2014

Growth is set to return to markets in the Commonwealth of Independent States between 2015 and 2019, according…

GenericsKazakhstanMarkets & MarketingPharmaceuticalRussiaUkraine

Cipla in deal with Teva for South African marketing

Cipla in deal with Teva for South African marketing

09-10-2014

Indian drugmaker Cipla has entered into a collaboration with Israel's Teva Pharmaceuticals Industries,…

CiplaGenericsMarkets & MarketingSouth AfricaTeva Pharmaceuticals Industries

Mylan debuts generic of ViiV’s Combivir in USA

Mylan debuts generic of ViiV’s Combivir in USA

06-10-2014

US generic drugmaker Mylan has launched of its Lamivudine and Zidovudine Tablets USP, 15mg/300mg, which…

Anti-viralsCombivirGenericsGlaxoSmithKlineMarkets & MarketingMylanUSAViiV Healthcare

Update: Negotiations on EU-Canada Free Trade Agreement concluded

Update: Negotiations on EU-Canada Free Trade Agreement concluded

29-09-2014

Canadian trade group Research-Based Pharmaceutical Companies (Rx&D) expressed its support to the government…

CanadaEuropeGenericsMarkets & MarketingPatentsPoliticsRegulation

Indian industry decries smear campaign against its pharma exporters

Indian industry decries smear campaign against its pharma exporters

26-09-2014

The India Brand Equity Foundation (IBEF), on behalf of the government of India, has taken strong objection…

Antibiotics and Infectious diseasesGenericsIndiaMarkets & MarketingPoliticsProductionUSA

Indian pharma envisages exports expansion, including in Latin American

Indian pharma envisages exports expansion, including in Latin American

16-09-2014

India Brand Equity Foundation (IBEF) today announced the sustained collective efforts being made by the…

FinancialGenericsIndiaMarkets & MarketingPatentsSouth America

Alchem International commits to tropane alkaloid APIs to resolve supply gap

15-09-2014

Following the decision by the principal European manufacturers to exit or end market development and…

Alchem InternationalGenericsIndiaMarkets & MarketingProductiontropane alkaloid

USA’s generic pharma savings reach highest-ever watermark

USA’s generic pharma savings reach highest-ever watermark

15-09-2014

The US Generic Pharmaceutical Association (GPhA) last week released a report showing that generic drugs…

BiosimilarsFinancialGenericsMarkets & MarketingUSA

Teva launches generic Baraclude in the USA

Teva launches generic Baraclude in the USA

04-09-2014

Israeli generics giant Teva Pharmaceutical Industries says it has launched its generic equivalent to…

Anti-viralsBaracludeBristol-Myers SquibbGenericsMarkets & MarketingTeva Pharmaceutical IndustriesUSA

1 to 25 of 321 results

Back to top